A5008857530- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Advanced Radiotherapy Techniques
- Urologic and reproductive health conditions
- Urinary Bladder and Prostate Research
- Bladder and Urothelial Cancer Treatments
- Sexual function and dysfunction studies
- Hormonal and reproductive studies
- Effects of Radiation Exposure
- Radiopharmaceutical Chemistry and Applications
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer, Lipids, and Metabolism
- Genital Health and Disease
- Urological Disorders and Treatments
- Statistical Methods in Clinical Trials
- Radiation Therapy and Dosimetry
- DNA Repair Mechanisms
- Colorectal Cancer Surgical Treatments
- Radiation Effects and Dosimetry
- Cervical Cancer and HPV Research
- Endometrial and Cervical Cancer Treatments
- BRCA gene mutations in cancer
- Advanced X-ray and CT Imaging
- Genetic factors in colorectal cancer
- Cancer Genomics and Diagnostics
Icahn School of Medicine at Mount Sinai
2016-2025
Mount Sinai Hospital
2009-2023
Mount Sinai Hospital
2022
Mount Sinai Hospital
1996-2020
University of Dayton
1990-2020
Goethe University Frankfurt
2020
New York Proton Center
2010-2019
Mount Sinai Medical Center
2009-2019
Servicio Gallego de Salud
2019
Complexo Hospitalario Universitario A Coruña
2019
<h3>Importance</h3> The optimal treatment for Gleason score 9-10 prostate cancer is unknown. <h3>Objective</h3> To compare clinical outcomes of patients with after definitive treatment. <h3>Design, Setting, and Participants</h3> Retrospective cohort study in 12 tertiary centers (11 the United States, 1 Norway), 1809 treated between 2000 2013. <h3>Exposures</h3> Radical prostatectomy (RP), external beam radiotherapy (EBRT) androgen deprivation therapy, or EBRT plus brachytherapy boost...
Urinary retention is a frequently reported complication following radioactive seed implantation of the prostate. If refractory, post-implant transurethral prostatic resection may ultimately be required to relieve obstruction, leading an increased risk urinary incontinence. In this series incidence prolonged was determined, and effect pretreatment treatment related factors analyzed identify high patients.A total 251 patients with organ confined prostate carcinoma underwent transperineal...
No AccessJournal of UrologyClinical Urology: Original Articles1 Nov 1997LAPAROSCOPIC PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER: COMPARISON OF THE EXTENDED AND MODIFIED TECHNIQUES Nelson N. Stone, Richard G. Stock, and Pamela Unger StoneNelson Stone , StockRichard Stock UngerPamela View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)64161-2AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract...
Abstract Background A total of 10%–20% patients develop long-term toxicity following radiotherapy for prostate cancer. Identification common genetic variants associated with susceptibility to radiotoxicity might improve risk prediction and inform functional mechanistic studies. Methods We conducted an individual patient data meta-analysis six genome-wide association studies (n = 3871) in men European ancestry who underwent Radiotoxicities (increased urinary frequency, decreased stream,...
We assess erectile function after prostate brachytherapy and analyze those factors affecting potency preservation.A total of 416 patients treated from October 1990 to September 1998 with permanent radioactive seed implantation for T1 T2 cancer had assessed before treatment. Erectile was using the scoring system 0-complete inability have erections, 1-able erections but insufficient intercourse, 2-can sufficient intercourse considered suboptimal 3-has normal function. Implant dose defined as...
Interactive, transrectal, ultrasound-guided transperineal implantation is a new technique for performing permanent brachytherapy implants of the prostate. Prostate specific antigen (PSA) findings, biopsy results, and morbidity are examined to demonstrate its efficacy safety in treating early stage prostate carcinoma.Ninety-seven patients underwent classifications T1 T2 adenocarcinoma gland with median follow-up 18 months (range: 6-51 months). Seventy-nine had negative laparoscopic pelvic...